Quest Diagnostics to offer lab tests through Apple Health app for $119
Get Alerts DGX Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.4%
Revenue Growth %: +7.8%
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) announced that Apple Health app users in the United States will be able to purchase a laboratory test panel directly through the app on iPhone and iPad later this year.
The panel includes over 50 biomarkers and is priced at $119. Users can schedule a blood draw and biometric readings at one of Quest's approximately 2,000 patient service centers across the country. Biometric readings included in the panel measure blood pressure, height, weight, and waist and hip circumferences.
Lab results will appear within the Apple Health app shortly after testing. Quest works with third-party providers to review and approve test orders and, at the user's request, discuss results and next steps at no additional charge.
Apple announced the upcoming integration at its September event.
"By embedding the Quest lab testing experience within the Apple Health app, we are making testing simpler, smarter and more available to people who want to connect biomarker and biometric insights to own their health," said Richard Adams, Senior Vice President and General Manager, Consumer, Quest Diagnostics.
The service will not be available in all U.S. states. According to the press release, the feature is expected to launch later in 2026.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iambic Therapeutics (IAM) files for proposed IPO
- Oliveda unit completes Demeter biodynamic audit for olive groves
- NBT Bancorp adds former Crouse Health CEO to its board
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share